ID
17654
Beschrijving
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Open-label Tarceva Consent and Eligibility
Link
https://clinicaltrials.gov/ct2/show/NCT00373425
Trefwoorden
Versies (2)
- 02-08-16 02-08-16 -
- 27-09-16 27-09-16 -
Geüploaded op
27 september 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Open-label Tarceva, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
Open-label Tarceva Consent and Eligibility, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Beschrijving
Open-label Tarceva Eligibility
Beschrijving
Open-label Tarceva Eligibility
Datatype
boolean
Alias
- UMLS CUI [1]
- C1516637
Beschrijving
Eligibility Criteria: OSI-774-302 Protocol Version 2, 21 November 2007, Appendix 12.9
Datatype
boolean
Alias
- UMLS CUI [1]
- C1302261
Beschrijving
Eligibility Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C1516637
Beschrijving
Eligibility Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C1516637
Beschrijving
Eligibility Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C1516637
Beschrijving
Eligibility Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C1516637
Beschrijving
Exemption
Datatype
integer
Alias
- UMLS CUI [1,1]
- C1516637
- UMLS CUI [1,2]
- C2348482
Beschrijving
Investigator Signature
Beschrijving
I have reviewed all data for this patient's eligibility and confirm that consent has been obtained in accordance with the GCP Directive (2005/28/EC) or EU Directive (2001/20/EC) and other applicable GCP requirements.
Datatype
text
Alias
- UMLS CUI [1]
- C2346576
Beschrijving
Investigator Signature Date
Datatype
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Open-label Tarceva Consent and Eligibility, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C1135136 (UMLS CUI [1,2])
C2348482 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])